Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Novel approaches for treating cardiovascular disease

A postgraduate research opportunity at the University of Otago.

Details

Academic background
Sciences, Health Sciences
Host campus
Dunedin
Qualifications
Master’s, PhD
Department
Physiology
Supervisor
Dr Jeff Erickson

Overview

Cardiovascular disease is the primary cause of death throughout most of the world, and existing therapeutic options are unsuitable for a large percentage of patients. Our group is exploring new targets in the heart and vessels to develop the next generation of cardiovascular treatments. Recent work from our group shows has identified a potential target: calcium/calmodulin dependent kinase II (CaMKII), a key protein mediator of cardiac and vascular dyfunction. We are seeking motivated students with an interest in cardiovascular physiology to join our team and examine the connection between CaMKII and cardiovascular disease. Projects in our group utilize state-of-the-art techniques and reagents, as well as genetic mouse models not available elsewhere in the world.

Candidates with a wide range of interests, including molecular and protein biochemistry, fluorescent imaging, and physiological techniques (ex. echocardiography, force development measurements in isolated fibers, etc.) are encouraged to apply.

Contact

Jeff Erickson
Email   jeff.erickson@otago.ac.nz